BiotechTube
Home/SynerFuse/Michael C. Park, MD, PhD
MC

Michael C. Park, MD, PhD

Chief Technology Officer

SynerFuse

Therapeutic Areas

Chronic PainNeuroscience

SynerFuse Pipeline

DrugIndicationPhase
NeuroFuse System / e-TLIF ProcedureChronic low back and leg pain in patients undergoing lumbar spinal fusionFeasibility

Leadership Team at SynerFuse

JZ
Justin Zenanko, CPA, MDiv
Chief Executive Officer & Founder
NR
Nameer R. Haider, MD, FAAPM&R, DABPM
Chief Innovation Officer
RL
Rohan Lall, MD
Chief Medical Officer
View full SynerFuse profile